Open access · CC-BY
via OpenAlex
Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson’s Disease
Joanna Agata Motyl, Joanna Benigna Strosznajder, Agnieszka Wencel, Robert Piotr Strosznajder
International Journal of Molecular Sciences · 2021 · ▲ 26 citations
Abstract
Molecular studies have provided increasing evidence that Parkinson's disease (PD) is a protein conformational disease, where the spread of alpha-synuclein (ASN) pathology along the neuraxis correlates with clinical disease outcome. Pathogenic forms of ASN evoke oxidative stress (OS), neuroinflammation, and protein alterations in neighboring cells, thereby intensifying ASN toxicity, neurodegeneration, and neuronal death. A number of evidence suggest that homeostasis between bioactive sphingolipids with opposing function-e.g., sphingosine-1-phosphate (S1P) and ceramide-is essential in pro-survival signaling and cell defense against OS. In contrast, imbalance of the "sphingolipid biostat" favoring pro-oxidative/pro-apoptotic ceramide-mediated changes have been indicated in PD and other neurodegenerative disorders. Therefore, we focused on the role of sphingolipid alterations in ASN burden, as well as in a vast range of its neurotoxic effects. Sphingolipid homeostasis is principally directed by sphingosine kinases (SphKs), which synthesize S1P-a potent lipid mediator regulating cell fate and inflammatory response-making SphK/S1P signaling an essential pharmacological target. A growing number of studies have shown that S1P receptor modulators, and agonists are promising protectants in several neurological diseases. This review demonstrates the relationship between ASN toxicity and alteration of SphK-dependent S1P signaling in OS, neuroinflammation, and neuronal death. Moreover, we discuss the S1P receptor-mediated pathways as a novel promising therapeutic approach in PD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms22126277
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Motyl, J.A., Strosznajder, J.B., Wencel, A., & Strosznajder, R.P. (2021). Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson’s Disease. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms22126277
Vancouver
Motyl JA, Strosznajder JB, Wencel A, Strosznajder RP. Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson’s Disease. International Journal of Molecular Sciences. 2021. doi:10.3390/ijms22126277.
BibTeX
@article{joanna2021Recent,
title = {Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson’s Disease},
author = {Joanna Agata Motyl and Joanna Benigna Strosznajder and Agnieszka Wencel and Robert Piotr Strosznajder},
journal = {International Journal of Molecular Sciences},
year = {2021},
doi = {10.3390/ijms22126277},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Brain Plasticity 2020
Open access · CC-BY
Preventing and Treating Neurological Disorders with the Flavonol Fisetin
Journal of Cellular and Molecular Medicine 2008
Preprint · OA
Immunological features of α‐synuclein in Parkinson's disease
Biomedicine & Pharmacotherapy 2021
Open access · CC-BY
Evidence and perspectives of cell senescence in neurodegenerative diseases
Frontiers in Pharmacology 2025
Open access · CC-BY
Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review
University of Bordeaux 2012
Open access · US-GOV
Based-virtual Reality Diagnosis for Neuropsychiatric Diseases and Sleep/Wake Disorders
Oxidative Medicine and Cellular Longevity 2020
Open access · CC-BY